High fat high cholesterol diet (Western Diet) aggravates atherosclerosis, hyperglycemia and renal failure in nephrectomized LDL receptor knockout mice: Role of intestine derived lipopolysaccharide

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Ghosh, Siddhartha S ^a   Righi, Samuel ^a   Krieg, Richard ^a   Kang, Le ^a   Carl, Daniel ^a   Wang, Jing ^a   Massey, H Davis ^a   Sica, Domenic A ^a   Gehr, Todd W B ^a   Ghosh, Shobha ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CURCUMIN; GLUCOSE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN RECEPTOR; POLYMYXIN; TUMOR NECROSIS FACTOR ALPHA; UREA; CHOLESTEROL; FAT INTAKE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; BODY WEIGHT; CELL INFILTRATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG EFFECT; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; KIDNEY FAILURE; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PROTEIN EXPRESSION; UREA NITROGEN BLOOD LEVEL; WESTERN DIET; ADVERSE EFFECTS; ANIMAL; DEFICIENCY; DISEASE MODEL; DRUG EFFECTS; FAT INTAKE; GENE EXPRESSION; GENETICS; HYPERGLYCEMIA; INTESTINE; KIDNEY; LIPID DIET; MACROPHAGE; METABOLISM; NEPHRECTOMY; PATHOLOGY; RENAL INSUFFICIENCY;

ANIMALS; ATHEROSCLEROSIS; CHOLESTEROL; CURCUMIN; DIET, HIGH-FAT; DIET, WESTERN; DIETARY FATS; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GLUCOSE INTOLERANCE; HYPERGLYCEMIA; INTESTINES; KIDNEY; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MICE, KNOCKOUT; NEPHRECTOMY; POLYMYXINS; RECEPTORS, LDL; RENAL INSUFFICIENCY;

EID: 84957542040     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0141109     Document Type: Article

References (60)

1. Odermatt A. The Western-style diet: a major risk factor for impaired kidney function and chronic kidney disease. Am J Physiol Renal Physiol. 2011; 301: F919-31. doi: 10.1152/ajprenal.00068.2011 PMID: 21880837
2. Nguyen S, Hsu CY. Excess weight as a risk factor for kidney failure. Curr Opin Nephrol Hypertens. 2007; 16: 71-76. PMID: 17293680
3. Zhao B, Song J, Chow WN, St Clair RW, Rudel LL, Ghosh S. Macrophage-specific transgenic expression of cholesteryl ester hydrolase significantly reduces atherosclerosis and lesion necrosis in Ldlr mice. J Clin Invest. 2007; 117: 2983-2992. PMID: 17885686
4. Bie J, Zhao B, Song J, Ghosh S. Improved insulin sensitivity in high fat-and high cholesterol-fed Ldlr-/-mice with macrophage-specific transgenic expression of cholesteryl ester hydrolase: role of macrophage inflammation and infiltration into adipose tissue. J Biol Chem. 2010; 285: 13630-13637. doi: 10. 1074/jbc.M109.069781 PMID: 20189995
5. Davies MR, Lund RJ, Mathew S, Hruska KA. Low turnover osteodystrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome. J Am Soc Nephrol. 2005; 16: 917-928. PMID: 15743994
6. Bro S, Bentzon JF, Falk E, Andersen CB, Olgaard K, Nielsen LB. Chronic renal failure accelerates atherogenesis in apolipoprotein E-deficient mice. J Am Soc Nephrol. 2003; 14: 2466-2474. PMID: 14514724
7. Yamamoto S, Yancey PG, Zuo Y, Ma LJ, Kaseda R, Fogo AB, et al. Macrophage polarization by angiotensin II-type 1 receptor aggravates renal injury-acceleration of atherosclerosis. Arterioscler Thromb Vasc Biol. 2011; 31: 2856-2864. doi: 10.1161/ATVBAHA.111.237198 PMID: 21979434
8. Veniant MM, Withycombe S, Young SG. Lipoprotein size and atherosclerosis susceptibility in Apoe(-/-) and Ldlr(-/-) mice. Arterioscler Thromb Vasc Biol. 2001; 21: 1567-1570. PMID: 11597927
9. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 2008; 57: 1470-1481. doi: 10.2337/db07-1403 PMID: 18305141
10. Murphy EF, Cotter PD, Hogan A, O'Sullivan O, Joyce A, Fouhy F, et al. Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity. Gut. 2013; 62: 220-226. doi: 10.1136/gutjnl-2011-300705 PMID: 22345653
11. Vrieze A, Van Nood E, Holleman F, Salojarvi J, Kootte RS, Bartelsman JF, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology. 2012; 143: 913-6.e7. doi: 10.1053/j.gastro.2012.06.031 PMID: 22728514
12. Niwa T. Targeting protein-bound uremic toxins in chronic kidney disease. Expert Opin Ther Targets. 2013; 17: 1287-1301. doi: 10.1517/14728222.2013.829456 PMID: 23941498
13. Davies B, Cohen J. Endotoxin removal devices for the treatment of sepsis and septic shock. Lancet Infect Dis. 2011; 11: 65-71. doi: 10.1016/S1473-3099(10)70220-6 PMID: 21183148
14. Ghosh SS, Massey HD, Krieg R, Fazelbhoy ZA, Ghosh S, Sica DA, et al. Curcumin ameliorates renal failure in 5/6 nephrectomized rats: role of inflammation. Am J Physiol Renal Physiol. 2009; 296: F1146-57. doi: 10.1152/ajprenal.90732.2008 PMID: 19225048
15. Ghosh SS, Krieg R, Massey HD, Sica DA, Fakhry I, Ghosh S, et al. Curcumin and enalapril ameliorate renal failure by antagonizing inflammation in 5/6 nephrectomized rats: role of phospholipase and cyclooxygenase. Am J Physiol Renal Physiol. 2012; 302: F439-54. doi: 10.1152/ajprenal.00356.2010 PMID: 22031851
16. Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J. 2013; 15: 195-218. doi: 10.1208/s12248-012-9432-8 PMID: 23143785
17. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007; 4: 807-818. PMID: 17999464
18. Ma LJ, Fogo AB. Model of robust induction of glomerulosclerosis in mice: importance of genetic background. Kidney Int. 2003; 64: 350-355. PMID: 12787428
19. Leelahavanichkul A, Yan Q, Hu X, Eisner C, Huang Y, Chen R, et al. Angiotensin II overcomes straindependent resistance of rapid CKD progression in a new remnant kidney mouse model. Kidney Int. 2010; 78: 1136-1153. doi: 10.1038/ki.2010.287 PMID: 20736988
20. Buzello M, Tornig J, Faulhaber J, Ehmke H, Ritz E, Amann K. The apolipoprotein e knockout mouse: a model documenting accelerated atherogenesis in uremia. J Am Soc Nephrol. 2003; 14: 311-316. PMID: 12538731
21. Adachi Y, Moore LE, Bradford BU, Gao W, Thurman RG. Antibiotics prevent liver injury in rats following long-term exposure to ethanol. Gastroenterology. 1995; 108: 218-224. PMID: 7806045
22. Emmelot CH, van der Waaij D. The dose at which neomycin and polymyxin B can be applied for selective decontamination of the digestive tract in mice. J Hyg (Lond). 1980; 84: 331-340.
23. Bie J, Zhao B, Ghosh S. Atherosclerotic lesion progression is attenuated by reconstitution with bone marrow from macrophage-specific cholesteryl ester hydrolase transgenic mice. Am J Physiol Regul Integr Comp Physiol. 2011; 301: R967-74. doi: 10.1152/ajpregu.00277.2011 PMID: 21795638
24. Wu H, Chen G, Wyburn KR, Yin J, Bertolino P, Eris JM, et al. TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest. 2007; 117: 2847-2859. PMID: 17853945
25. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS. Body mass index and risk for end-stage renal disease. Ann Intern Med. 2006; 144: 21-28. PMID: 16389251
26. Kalantar-Zadeh K, Kopple JD, Kilpatrick RD, McAllister CJ, Shinaberger CS, Gjertson DW, et al. Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population. Am J Kidney Dis. 2005; 46: 489-500. PMID: 16129211
27. Kovesdy CP, Kopple JD, Kalantar-Zadeh K. Management of protein-energy wasting in non-dialysisdependent chronic kidney disease: reconciling low protein intake with nutritional therapy. Am J Clin Nutr. 2013; 97: 1163-1177. doi: 10.3945/ajcn.112.036418 PMID: 23636234
28. Decleves AE, Zolkipli Z, Satriano J, Wang L, Nakayama T, Rogac M, et al. Regulation of lipid accumulation by AMK-activated kinase in high fat diet-induced kidney injury. Kidney Int. 2013.
29. Amar J, Burcelin R, Ruidavets JB, Cani PD, Fauvel J, Alessi MC, et al. Energy intake is associated with endotoxemia in apparently healthy men. Am J Clin Nutr. 2008; 87: 1219-1223. PMID: 18469242
30. Sun PP, Perianayagam MC, Jaber BL. Endotoxin-binding affinity of sevelamer: a potential novel antiinflammatory mechanism. Kidney Int Suppl. 2009; (114: ):S20-5. doi: 10.1038/ki.2009.403 PMID: 19946323
31. Terawaki H, Yokoyama K, Yamada Y, Maruyama Y, Iida R, Hanaoka K, et al. Low-grade endotoxemia contributes to chronic inflammation in hemodialysis patients: examination with a novel lipopolysaccharide detection method. Ther Apher Dial. 2010; 14: 477-482. doi: 10.1111/j.1744-9987.2010.00815.x PMID: 21175546
32. Vaziri ND, Yuan J, Rahimi A, Ni Z, Said H, Subramanian VS. Disintegration of colonic epithelial tight junction in uremia: a likely cause of CKD-associated inflammation. Nephrol Dial Transplant. 2012; 27: 2686-2693. doi: 10.1093/ndt/gfr624 PMID: 22131233
33. Ghosh SS, Bie J, Wang J, Ghosh S. Oral supplementation with non-absorbable antibiotics or curcumin attenuates western diet-induced atherosclerosis and glucose intolerance in LDLR-/-mice-role of intestinal permeability and macrophage activation. PLoS One. 2014; 9: e108577. doi: 10.1371/journal. pone.0108577 PMID: 25251395
34. Bentata Y, Abouqal R. Does albuminuria predict renal risk and/or cardiovascular risk in obese type 2 diabetic patients? Am J Cardiovasc Dis. 2014; 4: 26-30. PMID: 24551483
35. Pavkov ME, Knowler WC, Lemley KV, Mason CC, Myers BD, Nelson RG. Early renal function decline in type 2 diabetes. Clin J Am Soc Nephrol. 2012; 7: 78-84. doi: 10.2215/CJN.07610711 PMID: 22076874
36. Dutta D, Choudhuri S, Mondal SA, Mukherjee S, Chowdhury S. Urinary albumin: creatinine ratio predicts prediabetes progression to diabetes and reversal to normoglycemia: Role of associated insulin resistance, inflammatory cytokines and low vitamin D. J Diabetes. 2013.
37. Mak RH, Cheung W. Cachexia in chronic kidney disease: role of inflammation and neuropeptide signaling. Curr Opin Nephrol Hypertens. 2007; 16: 27-31. PMID: 17143068
38. Vaziri ND, Wong J, Pahl M, Piceno YM, Yuan J, DeSantis TZ, et al. Chronic kidney disease alters intestinal microbial flora. Kidney Int. 2013; 83: 308-315. doi: 10.1038/ki.2012.345 PMID: 22992469
39. Vaziri ND. CKD impairs barrier function and alters microbial flora of the intestine: a major link to inflammation and uremic toxicity. Curr Opin Nephrol Hypertens. 2012; 21: 587-592. PMID: 23010760
40. Anders HJ, Andersen K, Stecher B. The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease. Kidney Int. 2013; 83: 1010-1016. doi: 10.1038/ki.2012.440 PMID: 23325079
41. Kostic AD, Howitt MR, Garrett WS. Exploring host-microbiota interactions in animal models and humans. Genes Dev. 2013; 27: 701-718. doi: 10.1101/gad.212522.112 PMID: 23592793
42. Kubotera N, Prokopienko AJ, Garba AO, Pai AB. Endotoxin binding by sevelamer: potential impact on nutritional status. Int J Nephrol. 2013; 2013: 954956. doi: 10.1155/2013/954956 PMID: 23401772
43. Henricson BE, Manthey CL, Perera PY, Hamilton TA, Vogel SN. Dissociation of lipopolysaccharide (LPS)-inducible gene expression in murine macrophages pretreated with smooth LPS versus monophosphoryl lipid A. Infect Immun. 1993; 61: 2325-2333. PMID: 8388859
44. Deng H, Maitra U, Morris M, Li L. Molecular mechanism responsible for the priming of macrophage activation. J Biol Chem. 2013; 288: 3897-3906. doi: 10.1074/jbc.M112.424390 PMID: 23264622
45. West MA, Koons A. Endotoxin tolerance in sepsis: concentration-dependent augmentation or inhibition of LPS-stimulated macrophage TNF secretion by LPS pretreatment. J Trauma. 2008; 65: 893-8; discussion 898-900. PMID: 18849808
46. Maitra U, Deng H, Glaros T, Baker B, Capelluto DG, Li Z, et al. Molecular mechanisms responsible for the selective and low-grade induction of proinflammatory mediators in murine macrophages by lipopolysaccharide. J Immunol. 2012; 189: 1014-1023. doi: 10.4049/jimmunol.1200857 PMID: 22706082
47. Hirohashi N, Morrison DC. Low-dose lipopolysaccharide (LPS) pretreatment of mouse macrophages modulates LPS-dependent interleukin-6 production in vitro. Infect Immun. 1996; 64: 1011-1015. PMID: 8641750
48. Fessler MB, Rudel LL, Brown JM. Toll-like receptor signaling links dietary fatty acids to the metabolic syndrome. Curr Opin Lipidol. 2009; 20: 379-385. PMID: 19625959
49. Jialal I, Kaur H, Devaraj S. Toll-like receptor status in obesity and metabolic syndrome: a translational perspective. J Clin Endocrinol Metab. 2014; 99: 39-48. doi: 10.1210/jc.2013-3092 PMID: 24187406
50. Huang S, Rutkowsky JM, Snodgrass RG, Ono-Moore KD, Schneider DA, Newman JW, et al. Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways. J Lipid Res. 2012; 53: 2002-2013. doi: 10.1194/jlr.D029546 PMID: 22766885
51. Zhang X, Morrison DC. Lipopolysaccharide-induced selective priming effects on tumor necrosis factor alpha and nitric oxide production in mouse peritoneal macrophages. J Exp Med. 1993; 177: 511-516. PMID: 8426119
52. Liu Z, Jiang Y, Li Y, Wang J, Fan L, Scott MJ, et al. TLR4 Signaling augments monocyte chemotaxis by regulating G protein-coupled receptor kinase 2 translocation. J Immunol. 2013; 191: 857-864. doi: 10. 4049/jimmunol.1300790 PMID: 23772028
53. Soetikno V, Watanabe K, Sari FR, Harima M, Thandavarayan RA, Veeraveedu PT, et al. Curcumin attenuates diabetic nephropathy by inhibiting PKC-alpha and PKC-beta1 activity in streptozotocininduced type I diabetic rats. Mol Nutr Food Res. 2011; 55: 1655-1665. doi: 10.1002/mnfr.201100080 PMID: 22045654
54. Hasan ST, Zingg JM, Kwan P, Noble T, Smith D, Meydani M. Curcumin modulation of high fat dietinduced atherosclerosis and steatohepatosis in LDL receptor deficient mice. Atherosclerosis. 2014; 232: 40-51. doi: 10.1016/j.atherosclerosis.2013.10.016 PMID: 24401215
55. Aggarwal BB. Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Annu Rev Nutr. 2010; 30: 173-199. doi: 10.1146/annurev.nutr.012809.104755 PMID: 20420526
56. Al-Sadi R, Guo S, Ye D, Dokladny K, Alhmoud T, Ereifej L, et al. Mechanism of IL-1beta modulation of intestinal epithelial barrier involves p38 kinase and activating transcription factor-2 activation. J Immunol. 2013; 190: 6596-6606. doi: 10.4049/jimmunol.1201876 PMID: 23656735
57. Ma TY, Iwamoto GK, Hoa NT, Akotia V, Pedram A, Boivin MA, et al. TNF-alpha-induced increase in intestinal epithelial tight junction permeability requires NF-kappa B activation. Am J Physiol Gastrointest Liver Physiol. 2004; 286: G367-76. PMID: 14766535
58. Wang Y, Lu Z, Wu H, Lv F. Study on the antibiotic activity of microcapsule curcumin against foodborne pathogens. Int J Food Microbiol. 2009; 136: 71-74. doi: 10.1016/j.ijfoodmicro.2009.09.001 PMID: 19775769
59. Dempe JS, Scheerle RK, Pfeiffer E, Metzler M. Metabolism and permeability of curcumin in cultured Caco-2 cells. Mol Nutr Food Res. 2013; 57: 1543-1549. doi: 10.1002/mnfr.201200113 PMID: 22930441
60. Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci. 2008; 65: 1631-1652. doi: 10.1007/s00018-008-7452-4 PMID: 18324353